| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.72 | 0.004 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |